Mason Street Advisors LLC Sells 22,138 Shares of Metlife Inc (NYSE:MET)

Mason Street Advisors LLC decreased its holdings in Metlife Inc (NYSE:MET) by 16.3% during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 113,401 shares of the financial services provider’s stock after selling 22,138 shares during the quarter. Mason Street Advisors LLC’s holdings in Metlife were worth $5,348,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Old Port Advisors increased its stake in Metlife by 4.1% in the 2nd quarter. Old Port Advisors now owns 4,996 shares of the financial services provider’s stock valued at $252,000 after buying an additional 199 shares during the last quarter. Unison Advisors LLC increased its stake in Metlife by 1.0% in the 2nd quarter. Unison Advisors LLC now owns 21,133 shares of the financial services provider’s stock valued at $1,049,000 after buying an additional 200 shares during the last quarter. Gilbert & Cook Inc. increased its stake in Metlife by 5.2% in the 3rd quarter. Gilbert & Cook Inc. now owns 4,559 shares of the financial services provider’s stock valued at $215,000 after buying an additional 227 shares during the last quarter. Cornerstone Advisors Inc. increased its stake in Metlife by 27.8% in the 2nd quarter. Cornerstone Advisors Inc. now owns 1,052 shares of the financial services provider’s stock valued at $52,000 after buying an additional 229 shares during the last quarter. Finally, Brooks Moore & Associates Inc. increased its stake in Metlife by 4.1% in the 2nd quarter. Brooks Moore & Associates Inc. now owns 5,831 shares of the financial services provider’s stock valued at $290,000 after buying an additional 231 shares during the last quarter. 74.87% of the stock is currently owned by institutional investors and hedge funds.

Shares of MET stock traded up $0.39 during trading hours on Tuesday, hitting $49.61. 206,617 shares of the company were exchanged, compared to its average volume of 4,575,457. The firm has a fifty day simple moving average of $46.60 and a 200 day simple moving average of $47.43. The company has a current ratio of 0.15, a quick ratio of 0.15 and a debt-to-equity ratio of 0.21. Metlife Inc has a 52-week low of $37.76 and a 52-week high of $51.16. The stock has a market capitalization of $45.36 billion, a price-to-earnings ratio of 9.20, a P/E/G ratio of 1.11 and a beta of 1.12.

Metlife (NYSE:MET) last issued its quarterly earnings results on Wednesday, October 30th. The financial services provider reported $1.27 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.40 by ($0.13). Metlife had a return on equity of 8.82% and a net margin of 10.82%. The company had revenue of $16.92 billion for the quarter, compared to analysts’ expectations of $16.37 billion. During the same quarter in the previous year, the business earned $1.38 EPS. The company’s revenue for the quarter was up 3.2% on a year-over-year basis. Sell-side analysts anticipate that Metlife Inc will post 5.55 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Friday, December 13th. Stockholders of record on Tuesday, November 5th will be paid a dividend of $0.44 per share. The ex-dividend date is Monday, November 4th. This represents a $1.76 annualized dividend and a dividend yield of 3.55%. Metlife’s payout ratio is currently 32.65%.

Several equities research analysts have commented on MET shares. Citigroup decreased their price objective on shares of Metlife from $42.00 to $41.00 and set a “sell” rating for the company in a research note on Friday, September 13th. ValuEngine upgraded shares of Metlife from a “strong sell” rating to a “sell” rating in a research note on Monday, November 4th. UBS Group increased their price objective on shares of Metlife from $46.00 to $47.00 and gave the company a “neutral” rating in a research note on Thursday, October 10th. Morgan Stanley decreased their price objective on shares of Metlife from $54.00 to $53.00 and set an “equal weight” rating for the company in a research note on Tuesday, August 20th. Finally, B. Riley reiterated a “neutral” rating on shares of Metlife in a research note on Tuesday, October 15th. Three equities research analysts have rated the stock with a sell rating, five have issued a hold rating and five have issued a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus price target of $49.51.

Metlife Company Profile

MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.

Further Reading: Book Value Of Equity Per Share – BVPS Explained

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Metlife Inc (NYSE:MET).

Institutional Ownership by Quarter for Metlife (NYSE:MET)

Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.